Clinical Trials

NCT01012037 | COMPLETED | PHASE2

491 participants

Linagliptin 2.5 mg Twice Daily Versus 5 mg Once Daily as add-on Therapy to Twice Daily Metformin in Type 2 Diabetes

Study Type:

INTERVENTIONAL

Last Updated:

2014-06-27

Start Date:

2009-11-30

Completion:

2010-09-30

Conditions

• Diabetes Mellitus, Type 2

Interventions

• DRUG

Results Available

NCT00985985 | COMPLETED | PHASE3

723 participants

Efficacy and Safety Study of Nicotine Mint Lozenge (2mg and 4mg) in Smoking Cessation

Study Type:

INTERVENTIONAL

Last Updated:

2014-06-27

Start Date:

2009-05-31

Completion:

2011-03-31

Conditions

• Smoking

Interventions

• DRUG

Results Available

NCT00955916 | COMPLETED | PHASE2

38 participants

CLAG Gleevec in Relapsed or Refractory Acute Myeloid Leukemia (AML)

Study Type:

INTERVENTIONAL

Last Updated:

2014-06-27

Start Date:

2009-08-31

Completion:

2012-12-31

Conditions

• Leukemia

Interventions

• DRUG

Results Available

NCT00935220 | COMPLETED | PHASE1

41 participants

Pharmacokinetics and Pharmacodynamics Trial With Linagliptin (BI 1356) 5mg in African American Type 2 Diabetic Patients

Study Type:

INTERVENTIONAL

Last Updated:

2014-06-27

Start Date:

2009-06-30

Completion:

2010-08-31

Conditions

• Diabetes Mellitus, Type 2

Interventions

• DRUG

Results Available

NCT00926289 | COMPLETED | PHASE4

894 participants

Telmisartan 80mg Plus Hydrochlorothiazide 25mg First Line in Moderate or Severe Hypertension

Study Type:

INTERVENTIONAL

Last Updated:

2014-06-27

Start Date:

2009-06-30

Completion:

2010-04-30

Conditions

• Hypertension

Interventions

• DRUG

Results Available

NCT00901147 | COMPLETED | PHASE2

25 participants

Study of Bortezomib and Panobinostat in Treating Patients With Relapsed/Refractory Peripheral T-cell Lymphoma or NK/T-cell Lymphoma

Study Type:

INTERVENTIONAL

Last Updated:

2014-06-27

Start Date:

2009-11-30

Completion:

2014-01-31

Conditions

• Peripheral T-cell Lymphoma (Not Otherwise Specified)
• Angioimmunoblastic T-cell Lymphoma
• Extranodal NK/T-cell Lymphoma Nasal Type
• Enteropathy- Type T-cell Lymphoma
• Hepatosplenic T-cell Lymphoma
• Anaplastic Large Cell Lymphoma (ALCL) (ALK-1 Negative)
• Relapsed ALCL (ALK-1 Positive) Post Autologous Transplant

Interventions

• DRUG

No Results Yet

NCT00898807 | COMPLETED | PHASE3

186 participants

Citalopram for Agitation in Alzheimer's Disease

Study Type:

INTERVENTIONAL

Last Updated:

2014-06-27

Start Date:

2009-07-31

Completion:

2013-09-30

Conditions

• Alzheimer's Disease
• Agitation

Interventions

• DRUG

Results Available

NCT00887289 | COMPLETED

1504 participants

Non-interventional Observational Study on the Influence of Pramipexole on Sensory Symptoms of Restless Legs Syndrome (RLS)

Study Type:

OBSERVATIONAL

Last Updated:

2014-06-27

Start Date:

2009-04-30

Completion:

2009-10-31

Conditions

• Restless Legs Syndrome

Results Available

NCT00874302 | WITHDRAWN | PHASE3

0 participants

Safety and Efficacy of 25 and 50 mg Doses of Proellex® in Treating the Recurrence of Uterine Fibroid Symptoms

Study Type:

INTERVENTIONAL

Last Updated:

2014-06-27

Conditions

• Uterine Fibroids

Interventions

• DRUG

No Results Yet

NCT00845858 | COMPLETED | PHASE2

287 participants

Efficacy and Safety of Metoclopramide Nasal Spray Solution in Diabetic Patients With Gastroparesis

Study Type:

INTERVENTIONAL

Last Updated:

2014-06-27

Start Date:

2009-04-30

Completion:

2011-12-31

Conditions

• Gastroparesis
• Diabetic Gastroparesis
• Diabetes
• Diabetes Mellitus
• Delayed Gastric Emptying

Interventions

• DRUG

Results Available

NCT00824382 | COMPLETED | PHASE2

328 participants

Efficacy and Safety of 4 Weeks Treatment With Inhaled BI 1744 CL in Japanese Patients With COPD

Study Type:

INTERVENTIONAL

Last Updated:

2014-06-27

Start Date:

2009-01-31

Completion:

2010-03-31

Conditions

• Pulmonary Disease, Chronic Obstructive

Interventions

• DRUG

Results Available

NCT00819091 | COMPLETED | PHASE3

245 participants

Randomized, Double-blind (db), Placebo-controlled 18 Week Study of Linagliptin (BI 1356) in Type 2 Diabetic Patients With Insufficient Glycaemic Control on a Sulfonylurea Drug

Study Type:

INTERVENTIONAL

Last Updated:

2014-06-27

Start Date:

2008-12-31

Completion:

2010-01-31

Conditions

• Diabetes Mellitus, Type 2

Interventions

• DRUG

Results Available

NCT00818038 | COMPLETED

30 participants

A Proof of Concept Study to Evaluate the Effectiveness of Tysabri in Relapsing Remitting Multiple Sclerosis (RRMS) Patient Bladder Function

Study Type:

OBSERVATIONAL

Last Updated:

2014-06-27

Start Date:

2009-03-31

Completion:

2011-03-31

Conditions

• Relapsing-Remitting Multiple Sclerosis

Interventions

• DRUG

No Results Yet

NCT00796653 | COMPLETED | PHASE3

937 participants

Safety and Efficacy of BI 1744 CL in Patients With Chronic Obstructive Pulmonary Disease II

Study Type:

INTERVENTIONAL

Last Updated:

2014-06-27

Start Date:

2009-01-31

Completion:

2010-12-31

Conditions

• Pulmonary Disease, Chronic Obstructive

Interventions

• DRUG

Results Available

NCT00793624 | COMPLETED | PHASE3

906 participants

Safety and Efficacy of BI 1744 CL in Patients With Chronic Obstructive Pulmonary Disease I

Study Type:

INTERVENTIONAL

Last Updated:

2014-06-27

Start Date:

2009-02-28

Completion:

2010-12-31

Conditions

• Pulmonary Disease, Chronic Obstructive

Interventions

• DRUG

Results Available

NCT00782509 | COMPLETED | PHASE3

644 participants

12 / 48 wk Pivotal PFT vs PBO in COPD II

Study Type:

INTERVENTIONAL

Last Updated:

2014-06-27

Start Date:

2009-02-28

Completion:

2010-09-30

Conditions

• Pulmonary Disease, Chronic Obstructive

Interventions

• DRUG

Results Available

NCT00767676 | COMPLETED | PHASE1

259 participants

Contact Sensitization Potential of 828 Ointment

Study Type:

INTERVENTIONAL

Last Updated:

2014-06-27

Start Date:

2008-10-31

Completion:

2008-11-30

Conditions

• Healthy Volunteers

Interventions

• DEVICE

Results Available

NCT00749931 | COMPLETED | NA

664 participants

MarginProbe, a Device for Intraoperative Assessment of Margin Status in Breast Conservation Surgery

Study Type:

INTERVENTIONAL

Last Updated:

2014-06-27

Start Date:

2008-10-31

Completion:

2010-03-31

Conditions

• Breast Cancer

Interventions

• DEVICE
• PROCEDURE

Results Available

NCT00740051 | COMPLETED | PHASE3

227 participants

A Randomised, db, Placebo-controlled Study of BI 1356 for 18 Weeks Followed by a 34 Week Double-blind Extension Period (Placebo Patients Switched to Glimepiride) in Type 2 Diabetic Patients for Whom Treatment With Metformin is Inappropriate

Study Type:

INTERVENTIONAL

Last Updated:

2014-06-27

Start Date:

2008-08-31

Completion:

2010-08-31

Conditions

• Diabetes Mellitus, Type 2

Interventions

• DRUG

Results Available

NCT00736099 | COMPLETED | PHASE3

2122 participants

Safety and Efficacy of Linagliptin (BI 1356) as Monotherapy or in Combination in Type 2 DM

Study Type:

INTERVENTIONAL

Last Updated:

2014-06-27

Start Date:

2008-08-31

Completion:

2010-12-31

Conditions

• Diabetes Mellitus, Type 2

Interventions

• DRUG

Results Available

NCT00716092 | COMPLETED | PHASE2

121 participants

The Effect of Linagliptin (BI 1356) on 24h-glucose Control and Various Biomarkers in Type 2 Diabetic Patients

Study Type:

INTERVENTIONAL

Last Updated:

2014-06-27

Start Date:

2008-07-31

Completion:

2008-11-30

Conditions

• Diabetes Mellitus, Type 2

Interventions

• DRUG

Results Available

NCT00657046 | COMPLETED | PHASE2

85 participants

Safety and Benefit Study of Droxidopa to Treat Patients With Intradialytic Hypotension

Study Type:

INTERVENTIONAL

Last Updated:

2014-06-27

Start Date:

2007-12-31

Completion:

2009-01-31

Conditions

• Intradialytic Hypotension

Interventions

• DRUG

Results Available

NCT00618774 | COMPLETED | PHASE3

259 participants

An Open-label, Long-term Study of Telmisartan Plus Amlodipine Fixed-dose Combination

Study Type:

INTERVENTIONAL

Last Updated:

2014-06-27

Start Date:

2008-01-31

Completion:

2009-10-31

Conditions

• Hypertension

Interventions

• DRUG

Results Available

NCT00606086 | COMPLETED | PHASE2

140 participants

Safety and Efficacy of the Therapeutic Vaccine GI-5005 Combined With Pegylated Interferon Plus Ribavirin Standard of Care Therapy Versus Standard of Care Alone in Patients With Genotype 1 Chronic Hepatitis C Infection

Study Type:

INTERVENTIONAL

Last Updated:

2014-06-27

Start Date:

2007-12-31

Completion:

2012-11-30

Conditions

• Genotype 1 Chronic Hepatitis C

Interventions

• DRUG

Results Available

NCT00558428 | COMPLETED | PHASE3

1098 participants

Telmisartan/Amlodipine (80/5) vs. Telmisartan/Amlodipine (40/5) vs. Amlodipine 10 or 5 in Resistant Hypertension

Study Type:

INTERVENTIONAL

Last Updated:

2014-06-27

Start Date:

2007-10-31

Completion:

2008-09-30

Conditions

• Hypertension

Interventions

• DRUG

Results Available

NCT00558259 | COMPLETED | PHASE3

1353 participants

Twice-daily Oral Direct Thrombin Inhibitor Dabigatran Etexilate in the Long Term Prevention of Recurrent Symptomatic VTE

Study Type:

INTERVENTIONAL

Last Updated:

2014-06-27

Start Date:

2007-11-30

Completion:

2011-02-28

Conditions

• Venous Thromboembolism

Interventions

• DRUG

Results Available

NCT00472199 | COMPLETED | PHASE4

331 participants

Long-term Efficacy, Safety and Tolerability of Pramipexole in Patients With Idiopathic Moderate to Severe Restless Legs Syndrome (RLS)

Study Type:

INTERVENTIONAL

Last Updated:

2014-06-27

Start Date:

2007-05-31

Completion:

2008-07-31

Conditions

• Restless Legs Syndrome

Interventions

• DRUG

Results Available

NCT00467740 | COMPLETED | PHASE2

296 participants

Efficacy and Safety of 4 Weeks of Treatment With Inhaled BI 1744 CL in Patients With Asthma

Study Type:

INTERVENTIONAL

Last Updated:

2014-06-27

Start Date:

2007-05-31

Completion:

2008-10-31

Conditions

• Asthma

Interventions

• DRUG

Results Available

NCT00452400 | COMPLETED | PHASE2

409 participants

Efficacy and Safety of 4 Weeks Treatment With Inhaled BI 1744 CL in Patients With COPD.

Study Type:

INTERVENTIONAL

Last Updated:

2014-06-27

Start Date:

2007-03-31

Completion:

2008-01-31

Conditions

• Pulmonary Disease, Chronic Obstructive
• Asthma

Interventions

• DRUG

Results Available

NCT00440271 | TERMINATED | PHASE3

33 participants

SPRING: Safety, Efficacy, Pharmacokinetics of tipRanavir/r IN Race/Gender HIV+ Patients Randomized to TDM or SoC

Study Type:

INTERVENTIONAL

Last Updated:

2014-06-27

Start Date:

2007-02-28

Completion:

2008-10-31

Conditions

• HIV Infections

Interventions

• DRUG

Results Available

NCT00439517 | COMPLETED | PHASE2

302 participants

Study to Evaluate the Efficacy and Safety of FOLFOX-4 Plus Cetuximab Versus UFOX Plus Cetuximab.

Study Type:

INTERVENTIONAL

Last Updated:

2014-06-27

Start Date:

2007-02-28

Completion:

2009-06-30

Conditions

• Previously Untreated Metastatic Colorectal Cancer

Interventions

• DRUG

Results Available

NCT00256607 | COMPLETED

301 participants

Non-traditional Cardiovascular Risk Factors and Atherosclerosis in Type 2 Diabetes

Study Type:

OBSERVATIONAL

Last Updated:

2014-06-27

Start Date:

2007-06-30

Completion:

2008-05-31

Conditions

• Type 2 Diabetes Mellitus

No Results Yet

NCT00252525 | COMPLETED

400 participants

Correlation of Plasma Endothelial Cell Activity With Cardiovascular Events in Patients With Diabetes Mellitus Type 2

Study Type:

OBSERVATIONAL

Last Updated:

2014-06-27

Start Date:

2007-06-30

Completion:

2008-05-31

Conditions

• Type 2 Diabetes Mellitus

No Results Yet

NCT00177424 | TERMINATED | PHASE4

154 participants

Sertraline for Preventing Post-stroke Depression and Improving Rehabilitation Outcomes

Study Type:

INTERVENTIONAL

Last Updated:

2014-06-27

Start Date:

2004-07-31

Completion:

2007-10-31

Conditions

• Cerebrovascular Accident
• Depression

Interventions

• DRUG

No Results Yet

NCT00165854 | COMPLETED | PHASE2

46 participants

Study of E7070 Combined With Capecitabine to Determine Efficacy and Recommended Dose of Combination in Patients With Metastatic Colorectal Cancer

Study Type:

INTERVENTIONAL

Last Updated:

2014-06-27

Start Date:

2003-03-31

Conditions

• Colorectal Cancer (CRC)

Interventions

• DRUG

No Results Yet

NCT00165828 | TERMINATED | PHASE4

157 participants

Efficacy and Safety of an add-on Treatment With Zonisamide in Adults With Focal Epileptic Seizures With or Without Secondary Generalization

Study Type:

INTERVENTIONAL

Last Updated:

2014-06-27

Start Date:

2005-05-31

Completion:

2008-02-29

Conditions

• Epilepsy

Interventions

• DRUG

No Results Yet

NCT00113607 | COMPLETED | PHASE3

672 participants

An Efficacy and Safety Study for Yondelis (Trabectedin) in Patients With Advanced Relapsed Ovarian Cancer

Study Type:

INTERVENTIONAL

Last Updated:

2014-06-27

Start Date:

2005-04-30

Completion:

2010-11-30

Conditions

• Ovarian Cancer

Interventions

• DRUG

Results Available

NCT02176109 | UNKNOWN

80 participants

Metabolism Des LAM

Study Type:

OBSERVATIONAL

Last Updated:

2014-06-26

Start Date:

2013-06-30

Completion:

2015-06-30

Conditions

• Iron
• Acute Myeloid Leukemia
• Diagnosis
• Oxydative Stress

No Results Yet

NCT02176070 | COMPLETED

467 participants

Reproductive Health in Men and Women With Vasculitis

Study Type:

OBSERVATIONAL

Last Updated:

2014-06-26

Start Date:

2011-02-28

Completion:

2012-03-31

Conditions

• Giant Cell Arteritis
• Takayasu's Arteritis
• Polyarteritis Nodosa
• Wegener's Granulomatosis
• Microscopic Polyangiitis
• Churg-Strauss Syndrome
• Behcet's Disease
• Kawasaki Disease
• Henoch-schoenlein Purpura
• Vasculitis, Central Nervous System
• Drug-induced Necrotizing Vasculitis

No Results Yet

NCT02175940 | COMPLETED

40 participants

VEGF and PEDF in Patients With Myopic Choroidal Neovascularization

Study Type:

OBSERVATIONAL

Last Updated:

2014-06-26

Start Date:

2013-07-31

Completion:

2014-01-31

Conditions

• Myopic Choroidal Neovascularization
• VEGF Aqueous Level
• PEDF Aqueous Level

No Results Yet